secobarbital will lessen the level or effect of fedratinib by impacting hepatic/intestinal enzyme CYP3A4 metabolism. Steer clear of or Use Alternate Drug. Effect of coadministering a robust CYP3A4 inducer with fedratinib hasn't been studied.
Find out how groundbreaking study is popping "undruggable" targets into therapeutic prospects.
secobarbital will decrease the extent or effect of fosaprepitant by affecting hepatic/intestinal enzyme CYP3A4 metabolism. Use Warning/Keep track of.
secobarbital will reduce the level or effect of fostemsavir by impacting hepatic/intestinal enzyme CYP3A4 metabolism. Contraindicated.
secobarbital will lessen the extent or effect of estropipate by influencing hepatic/intestinal enzyme CYP3A4 metabolism. Use Caution/Monitor.
If you think there has been an overdose, simply call your poison Regulate center or get medical care without delay. Be able to notify or exhibit what was taken, how much, and when it occurred.
secobarbital will lower the level or effect of pantoprazole by influencing hepatic/intestinal enzyme CYP3A4 metabolism. Use Caution/Keep an eye on.
This materials is furnished for academic uses only and isn't intended for medical tips, analysis, or treatment. Review our healthcare disclaimer.
Please include your email address if you are content to get contacted about your feedback. OUP will not likely use this email tackle seconal addiction treatment systems for virtually any other intent.
secobarbital will lower the extent or effect of isavuconazonium sulfate by affecting hepatic/intestinal enzyme CYP3A4 metabolism. Contraindicated.
secobarbital will reduce the extent or effect of doxorubicin by impacting hepatic/intestinal enzyme CYP3A4 metabolism. Use Warning/Keep an eye on.
Barbiturates easily cross the placental barrier and are dispersed in the course of fetal tissues; the highest concentrations are found in the placenta, fetal liver, and Mind. Fetal blood concentrations tactic maternal blood degrees following parenteral administration.
secobarbital will lessen the extent or effect of elvitegravir/cobicistat/emtricitabine/tenofovir DF by affecting hepatic/intestinal enzyme CYP3A4 metabolism. Contraindicated.
secobarbital will reduce the level or effect of duvelisib by affecting hepatic/intestinal enzyme CYP3A4 metabolism. Keep away from or Use Alternate Drug. Coadministration with a robust CYP3A inducer decreases duvelisib spot under the curve (AUC), which may perhaps reduce duvelisib efficacy.